Commission Implementing Regulation (EU) 2020/2235Dangos y teitl llawn

Commission Implementing Regulation (EU) 2020/2235 of 16 December 2020 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates, model official certificates and model animal health/official certificates, for the entry into the Union and movements within the Union of consignments of certain categories of animals and goods, official certification regarding such certificates and repealing Regulation (EC) No 599/2004, Implementing Regulations (EU) No 636/2014 and (EU) 2019/628, Directive 98/68/EC and Decisions 2000/572/EC, 2003/779/EC and 2007/240/EC (Text with EEA relevance)

Article 16U.K.Model animal health/official certificates for the entry into the Union of raw milk, dairy products, colostrum and colostrum-based products intended for human consumption

The animal health/official certificates referred to in Article 1(3)(b)(ii) to be used for the entry into the Union of raw milk, dairy products, colostrum and colostrum-based products intended for human consumption shall correspond to one of the following models, depending on the species and categories of products concerned:

(a)

MILK-RM drawn up in accordance with the model set out in Chapter 33 of Annex III, for raw milk intended for human consumption;

(b)

MILK-RMP/NT drawn up in accordance with the model set out in Chapter 34 of Annex III, for dairy products intended for human consumption derived from raw milk or that are not required to undergo a specific risk-mitigating treatment;

(c)

DAIRY-PRODUCTS-PT drawn up in accordance with the model set out in Chapter 35 of Annex III, for dairy products intended for human consumption that are required to undergo a pasteurization treatment;

(d)

DAIRY-PRODUCTS-ST drawn up in accordance with the model set out in Chapter 36 of Annex III, for dairy products intended for human consumption that are required to undergo a specific risk-mitigating treatment other than pasteurization;

(e)

COLOSTRUM drawn up in accordance with the model set out in Chapter 37 of Annex III, for colostrum intended for human consumption;

(f)

COLOSTRUM-BP drawn up in accordance with the model set out in Chapter 38 of Annex III, for colostrum-based products intended for human consumption.